August 13, 2026

Patrick Reid, President & CEO of PeptiDream, the parent company of PDRadiopharma, was recently featured in Nikkei’s “Business TODAY,” where he shared PeptiDream’s growth strategy and ambitions for the future of radiopharmaceuticals.

As part of the PeptiDream Group, PDRadiopharma will continue to expand the possibilities of radiopharmaceuticals and work toward bringing innovative diagnostics and therapies to patients as quickly as possible.

We invite you to read the full article.

Read the article:
Nikkei Business TODAY
ペプチドリーム、32年に初の自社医薬品　夢の単独開発で問われる覚悟
※Please note that access to the article requires registration with the Nikkei Online Edition (free or paid membership).